88 results
8-K
EX-10.4
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
of financial statements in conformity with generally accepted accounting principles and to maintain asset accountability, (iii) access to assets … to information supplied by, the Company or the Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity to correct
8-K
EX-10.2
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
) access to assets is permitted only in accordance with management’s general or specific authorization and (iv) the recorded accountability for assets … to information supplied by, the Company or the Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity
8-K
EX-10.6
exgn3wjorxlywma
10 May 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
m5d58fzwj084
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-10.3
2x261ig710b slb
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-10.4
7ghysbe9r0tkskjvmscc
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
e70c50sdwfl9vrm97rj
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
cqtamlpk wcg9sgl
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.4
efmuf9gj
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.24.1
qrt5mhps
5 Oct 23
Index to Financial Statements
5:12pm